NPR1 and prediabetes syndrome: Despite similar body weight gain (Fig. 7B), mice injected with AAV-Cre developed systemic insulin resistance based on HOMA-IR (Fig. 7C), as well as clear signs of prediabetes, as previously observed in Nppa−/− and Npr1+/− mice.